Lucas Ward
Stock Analyst at Ascendiant Capital
(0.38)
# 4,267
Out of 5,114 analysts
25
Total ratings
20%
Success rate
-34.93%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Maintains: Buy | $6.5 → $5.5 | $1.97 | +179.19% | 5 | Dec 3, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $3 → $2.8 | $0.76 | +268.91% | 4 | Nov 28, 2025 | |
| ACON Aclarion | Maintains: Buy | $22 → $23 | $6.20 | +270.97% | 5 | Nov 20, 2025 | |
| LIQT LiqTech International | Maintains: Buy | $4 → $4.2 | $1.83 | +129.51% | 6 | Nov 20, 2025 | |
| HSCS HeartSciences | Maintains: Buy | $15 → $9 | $2.36 | +281.36% | 3 | Oct 1, 2025 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $0.25 | +1,078,174.76% | 2 | Jul 29, 2024 |
Vivos Therapeutics
Dec 3, 2025
Maintains: Buy
Price Target: $6.5 → $5.5
Current: $1.97
Upside: +179.19%
60 Degrees Pharmaceuticals
Nov 28, 2025
Maintains: Buy
Price Target: $3 → $2.8
Current: $0.76
Upside: +268.91%
Aclarion
Nov 20, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $6.20
Upside: +270.97%
LiqTech International
Nov 20, 2025
Maintains: Buy
Price Target: $4 → $4.2
Current: $1.83
Upside: +129.51%
HeartSciences
Oct 1, 2025
Maintains: Buy
Price Target: $15 → $9
Current: $2.36
Upside: +281.36%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $0.25
Upside: +1,078,174.76%